Payment overview · 2025
General Payments
$802.30
28 reported records · 9 companies
Healthcare provider profile · identity verified
Ferdinant Saran, MD
Allopathic & Osteopathic Physicians|Internal Medicine · GLENDALE, CA · NPI 1245280007
Verified facts
What the public records show
CMS Open Payments records show Ferdinant Saran, MD received $802.30 in general payments during 2025 across 28 reported records.
Amgen Inc. accounted for 30.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 13 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Gemtesa, Linzess, Mounjaro, Prolia.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 636 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Synthroid by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 130 claims for Prolia by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 255 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Trulicity by this doctor in 2024.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Gemtesa by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $248.08 | 30.9% | 12 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $164.78 | 20.5% | 5 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $146.30 | 18.2% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $78.71 | 9.8% | 3 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $43.61 | 5.4% | 2 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $35.32 | 4.4% | 1 | 2025 |
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $32.17 | 4.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $28.79 | 3.6% | 1 | 2025 |
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $24.54 | 3.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $802.30 | 28 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $164.78 | 5 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $146.30 | 2 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $133.57 | 5 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $114.51 | 7 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $76.08 | 4 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $51.97 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $43.61 | 2 | 2025 |
Source payment records
|
|||||
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $32.17 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $30.91 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $28.79 | 1 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $26.74 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $26.38 | 1 | 2025 |
Source payment records
|
|||||
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $24.54 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| GEMTESA gemtesa |
2025 | Gemtesa | 2024 | 54 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 636 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| PROLIA prolia |
2025 | Prolia | 2024 | 130 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
636 | 98 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
130 | 78 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
255 | 48 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | GEMTESA open payments reported associated product |
CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503 |
Gemtesa · 2024 Exact normalized brand match · 1 Part D row |
54 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 2096 | 342 |
| Atorvastatin Calcium | Atorvastatin Calcium | 2064 | 322 |
| Amlodipine Besylate | Amlodipine Besylate | 2017 | 300 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1387 | 190 |
| Metoprolol Succinate | Metoprolol Succinate | 1105 | 164 |
| Losartan Potassium | Losartan Potassium | 1081 | 172 |
| Gabapentin | Gabapentin | 1064 | 178 |
| Omeprazole | Omeprazole | 1041 | 174 |
| Pantoprazole Sodium | Pantoprazole Sodium | 975 | 143 |
| Metformin Hcl | Metformin Hcl | 881 | 147 |
| Furosemide | Furosemide | 832 | 145 |
| Donepezil Hcl | Donepezil Hcl | 819 | 124 |
| Tamsulosin Hcl | Tamsulosin Hcl | 788 | 136 |
| Clopidogrel | Clopidogrel Bisulfate | 704 | 101 |
| Alendronate Sodium | Alendronate Sodium | 667 | 109 |
| Eliquis | Apixaban | 664 | 85 |
| Sertraline Hcl | Sertraline Hcl | 648 | 88 |
| Linzess | Linaclotide | 636 | 98 |
| Escitalopram Oxalate | Escitalopram Oxalate | 611 | 92 |
| Simvastatin | Simvastatin | 588 | 88 |
| Clonidine Hcl | Clonidine Hcl | 577 | 130 |
| Carvedilol | Carvedilol | 564 | 84 |
| Hydralazine Hcl | Hydralazine Hcl | 562 | 95 |
| Ezetimibe | Ezetimibe | 561 | 82 |
| Memantine Hcl | Memantine Hcl | 559 | 70 |
| Vascepa | Icosapent Ethyl | 544 | 91 |
| Allopurinol | Allopurinol | 529 | 68 |
| Januvia | Sitagliptin Phosphate | 510 | 72 |
| Alprazolam | Alprazolam | 501 | 117 |
| Finasteride | Finasteride | 445 | 71 |
| Metoprolol Tartrate | Metoprolol Tartrate | 433 | 63 |
| Icosapent Ethyl | Icosapent Ethyl | 419 | 98 |
| Lisinopril | Lisinopril | 415 | 71 |
| Tramadol Hcl | Tramadol Hcl | 410 | 83 |
| Azithromycin | Azithromycin | 404 | 285 |
| Famotidine | Famotidine | 386 | 96 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 365 | 57 |
| Diclofenac Sodium | Diclofenac Sodium | 361 | 88 |
| Myrbetriq | Mirabegron | 358 | 53 |
| Zolpidem Tartrate | Zolpidem Tartrate | 358 | 73 |
| Nifedipine Er | Nifedipine | 345 | 48 |
| Clonazepam | Clonazepam | 343 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 340 | 61 |
| Trazodone Hcl | Trazodone Hcl | 320 | 54 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 313 | 143 |
| Buspirone Hcl | Buspirone Hcl | 304 | 60 |
| Mirtazapine | Mirtazapine | 285 | 60 |
| Atenolol | Atenolol | 279 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 271 | 46 |
| Meloxicam | Meloxicam | 269 | 75 |
| Lorazepam | Lorazepam | 263 | 44 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 261 | 83 |
| Jardiance | Empagliflozin | 255 | 48 |
| Ibuprofen | Ibuprofen | 243 | 91 |
| Celecoxib | Celecoxib | 241 | 52 |
| Potassium Chloride | Potassium Chloride | 238 | 38 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 236 | 29 |
| Quetiapine Fumarate | Quetiapine Fumarate | 230 | 39 |
| Glimepiride | Glimepiride | 228 | 42 |
| Montelukast Sodium | Montelukast Sodium | 228 | 30 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 227 | 129 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 217 | 25 |
| Primidone | Primidone | 207 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 206 | 121 |
| Prednisone | Prednisone | 200 | 99 |
| Tradjenta | Linagliptin | 199 | 25 |
| Dexlansoprazole Dr | Dexlansoprazole | 193 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 192 | 33 |
| Meclizine Hcl | Meclizine Hcl | 189 | 50 |
| Xarelto | Rivaroxaban | 188 | 19 |
| Methimazole | Methimazole | 183 | 25 |
| Fenofibrate | Fenofibrate Nanocrystallized | 180 | 26 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 176 | 33 |
| Amiodarone Hcl | Amiodarone Hcl | 167 | 28 |
| Glipizide | Glipizide | 162 | 27 |
| Temazepam | Temazepam | 159 | 46 |
| Divalproex Sodium | Divalproex Sodium | 145 | 16 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 144 | 21 |
| Benazepril Hcl | Benazepril Hcl | 142 | 21 |
| Propranolol Hcl | Propranolol Hcl | 136 | 21 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 132 | 19 |
| Risperidone | Risperidone | 132 | 19 |
| Prolia | Denosumab | 130 | 78 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 127 | 21 |
| Clonidine | Clonidine | 127 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 124 | 105 |
| Irbesartan | Irbesartan | 124 | 21 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 123 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 122 | 29 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 120 | 25 |
| Amitriptyline Hcl | Amitriptyline Hcl | 119 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 116 | 18 |
| Ranolazine Er | Ranolazine | 112 | 16 |
| Clotrimazole | Clotrimazole | 111 | 29 |
| Nortriptyline Hcl | Nortriptyline Hcl | 108 | 16 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 105 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 104 | 20 |
| Loperamide | Loperamide Hcl | 103 | 47 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 102 | 21 |
| Valsartan | Valsartan | 101 | 17 |
| Entresto | Sacubitril/Valsartan | 100 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 100 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 100 | 30 |
| Dicyclomine Hcl | Dicyclomine Hcl | 99 | 40 |
| Digoxin | Digoxin | 96 | 13 |
| Hydrocortisone | Hydrocortisone | 96 | 38 |
| Paroxetine Hcl | Paroxetine Hcl | 95 | 15 |
| Baclofen | Baclofen | 93 | 28 |
| Telmisartan | Telmisartan | 91 | 12 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 89 | 25 |
| Dutasteride | Dutasteride | 88 | 15 |
| Fenofibrate | Fenofibrate | 86 | 16 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 86 | 14 |
| Naproxen | Naproxen | 85 | 50 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 84 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 16 |
| Nitroglycerin | Nitroglycerin | 83 | 24 |
| Enalapril Maleate | Enalapril Maleate | 78 | 13 |
| Repatha Sureclick | Evolocumab | 78 | 17 |
| Bumetanide | Bumetanide | 72 | 12 |
| Pregabalin | Pregabalin | 72 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 70 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 70 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 18 |
| Metoclopramide Hcl | Metoclopramide Hcl | 69 | 39 |
| Cephalexin | Cephalexin | 67 | 55 |
| Paxlovid | Nirmatrelvir/Ritonavir | 66 | 65 |
| Belsomra | Suvorexant | 65 | 18 |
| Ozempic | Semaglutide | 65 | 12 |
| Ketoconazole | Ketoconazole | 64 | 27 |
| Doxazosin Mesylate | Doxazosin Mesylate | 63 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 63 | 47 |
| Memantine Hcl Er | Memantine Hcl | 61 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 60 | 24 |
| Farxiga | Dapagliflozin Propanediol | 59 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 58 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 58 | 17 |
| Ramipril | Ramipril | 57 | suppressed |
| Gemtesa | Vibegron | 54 | suppressed |
| Spironolactone | Spironolactone | 54 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 53 | 20 |
| Bupropion Xl | Bupropion Hcl | 53 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 43 |
| Sumatriptan Succinate | Sumatriptan Succinate | 53 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 52 | 16 |
| Glipizide Er | Glipizide | 52 | suppressed |
| Repatha Pushtronex | Evolocumab | 51 | 12 |
| Midodrine Hcl | Midodrine Hcl | 50 | suppressed |
| Procto-Med Hc | Hydrocortisone | 50 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 48 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 47 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | 28 |
| Flecainide Acetate | Flecainide Acetate | 45 | suppressed |
| Lovastatin | Lovastatin | 45 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 45 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 43 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 43 | 36 |
| Ipratropium Bromide | Ipratropium Bromide | 42 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | suppressed |
| Erythromycin | Erythromycin Base | 41 | 32 |
| Multaq | Dronedarone Hcl | 41 | suppressed |
| Repaglinide | Repaglinide | 41 | suppressed |
| Sotalol | Sotalol Hcl | 41 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 39 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 37 | suppressed |
| Lidocaine | Lidocaine | 37 | suppressed |
| Metolazone | Metolazone | 37 | suppressed |
| Praluent Pen | Alirocumab | 37 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 35 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 35 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 35 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 35 | 29 |
| Bethanechol Chloride | Bethanechol Chloride | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 33 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 32 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 32 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | 17 |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Verapamil Er | Verapamil Hcl | 31 | suppressed |
| Metronidazole | Metronidazole | 30 | 23 |
| Mirabegron Er | Mirabegron | 30 | 13 |
| Rivastigmine | Rivastigmine | 30 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Nateglinide | Nateglinide | 29 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 21 |
| Imipramine Hcl | Imipramine Hcl | 27 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Latanoprost | Latanoprost | 26 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Ciclopirox | Ciclopirox | 24 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Cyclosporine | Cyclosporine | 23 | suppressed |
| Eszopiclone | Eszopiclone | 23 | suppressed |
| Fluocinonide | Fluocinonide | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Dexilant | Dexlansoprazole | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Mupirocin | Mupirocin | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 17 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 18 |
| Nystatin | Nystatin | 20 | 15 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 19 | suppressed |
| Alogliptin | Alogliptin Benzoate | 19 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 16 |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 18 | 16 |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Ibu | Ibuprofen | 17 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 16 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Clemastine Fumarate | Clemastine Fumarate | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Azathioprine | Azathioprine | 13 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Dofetilide | Dofetilide | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Mounjaro | Tirzepatide | 13 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Probenecid | Probenecid | 13 | suppressed |
| Sprintec | Norgestimate-Ethinyl Estradiol | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 12 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Livalo | Pitavastatin Calcium | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Nexium | Esomeprazole Magnesium | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Propylthiouracil | Propylthiouracil | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Triazolam | Triazolam | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Adlarity | Donepezil Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $802.30 · 28 records | Amgen Inc. | Cologuard Collection Kit, EVENITY, GEMTESA, IBSRELA, LINZESS, MOUNJARO, OTEZLA, PROLIA, REPATHA, REXULTI, REZDIFFRA, VRAYLAR, ZEPBOUND | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Gemtesa play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error